Myriad Genetics
MYGN • NASDAQ
Myriad Genetics is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Samraat S. Raha, with a market cap of $415.2M.
Market Cap$415.2M
Employees2.7K
CEOSamraat S. Raha
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Myriad Genetics FAQ
Common questions about Myriad Genetics
Myriad Genetics is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $202.3M.
Myriad Genetics has approximately 2,700 employees.